Desq Long
Sign in

Company

Actinium Pharmaceuticals, Inc.

ATNM · CIK 0001388320

SEC FORM 4
$0.00

Actinium Pharmaceuticals, Inc. (ATNM)

Acquisition (code A) of 61,600 shares at $0 per share.

Reporting Person Chell Jeffrey W. · Transaction Code A

Traded Sep 2, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001213900-26-097739 · filed 2026-09-04 · View filing →

SEC FORM 4
$0.00

Actinium Pharmaceuticals, Inc. (ATNM)

Acquisition (code A) of 62,800 shares at $0 per share.

Reporting Person Steinhart Richard I · Transaction Code A

Traded Sep 2, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001213900-26-097740 · filed 2026-09-04 · View filing →

SEC FORM 4
$0.00

Actinium Pharmaceuticals, Inc. (ATNM)

Acquisition (code A) of 753,600 shares at $0 per share.

Reporting Person SETH SANDESH · Officer Title Chief Executive Officer · Transaction Code A

Traded Sep 2, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001213900-26-097741 · filed 2026-09-04 · View filing →

SEC FORM 4
$0.00

Actinium Pharmaceuticals, Inc. (ATNM)

Acquisition (code A) of 1,027,274 shares at $0 per share.

Reporting Person SETH SANDESH · Officer Title Chief Executive Officer · Transaction Code A

Traded Sep 2, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001213900-26-097741 · filed 2026-09-04 · View filing →

SEC FORM 4
$0.00

Actinium Pharmaceuticals, Inc. (ATNM)

Acquisition (code A) of 18,000 shares at $0 per share.

Reporting Person Almenoff June Sherie · Transaction Code A

Traded Sep 2, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001213900-26-097742 · filed 2026-09-04 · View filing →

SEC FORM 4
$0.00

Actinium Pharmaceuticals, Inc. (ATNM)

Acquisition (code A) of 61,600 shares at $0 per share.

Reporting Person Shetty Ajit · Transaction Code A

Traded Sep 2, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001213900-26-097744 · filed 2026-09-04 · View filing →

SEC FORM 4
$0.00

Actinium Pharmaceuticals, Inc. (ATNM)

Acquisition (code A) of 62,800 shares at $0 per share.

Reporting Person Nicholson, C. David · Transaction Code A

Traded Sep 2, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001213900-26-097745 · filed 2026-09-04 · View filing →